发明名称 TRIAZOLOPYRIMIDINE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3 INHIBITORS
摘要 This invention concerns compounds of formula (I) a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine and a stereochernically isomeric form thereof, wherein ring A represents phenyl, pyridyl, pyrimidinyl, pyridazinyl or pyrazinyl; R<SUP>1</SUP> represents hydrogen; aryl; formyl; C<SUB>1-6</SUB> alkylcarbonyl; C<SUB>1-6</SUB> a]kyl; C<SUB>1-6</SUB> alkyloxycarbonyl; C<SUB>1-6</SUB> alkyl substituted with formyl, C<SUB>1-6</SUB>alkylcarbonyl, C<SUB>1-6</SUB>alkyloxycarbonyl, C<SUB>1-6</SUB>alkylcarbonytoxy; or optionally substituted C<SUB>1-6</SUB> alkyloxyCl-6alkylcarbonyl; X<SUB>1</SUB> represents a direct bond; -(CH<SUB>2</SUB>)<SUB>n3</SUB>- or -(CH<SUB>2</SUB>)<SUB>n4</SUB>-X<SUB>1a</SUB>-X<SUB>1b</SUB>-; R<SUP>2</SUP> represents optionally substituted C<SUB>3-7</SUB>CYCloalkyl; phenyl; a 4, 5, 6- or 7-membered monocyclic heterocycle containing at least one heteroatorn selected from 0, S or N; benzoxazolyl or a radical of formula (a-1); X<SUB>2</SUB> represents a direct bond; -NR<SUP>1</SUP>-NR<SUP>1</SUP>-(CH<SUB>2</SUB>)<SUB>N3</SUB> -; -0-; -0-(CH<SUB>2</SUB>)<SUB>n3</SUB>-; -C(=O)-; -C(=O)- (CH<SUB>2</SUB>)<SUB>n3</SUB>-; -C(=O)-NR<SUP>5</SUP>-(CH<SUB>2</SUB>)<SUB>n3</SUB>-; -C(=S)-; -S-; -S(=O)<SUB>n1</SUB>-; -(CH<SUB>2</SUB>)<SUB>n3</SUB>-; -(CH<SUB>2</SUB>)<SUB>n4</SUB>-X<SUB>1a</SUB>-X<SUB>1b</SUB>-; -X<SUB>1a</SUB>.-X<SUB>1b</SUB>-(CH<SUB>2</SUB>)<SUB>n4</SUB>-; -S(=O)<SUB>n1</SUB>-NR<SUP>5</SUP>-(CH<SUB>2</SUB>)<SUB>n3</SUB>-NR<SUP>5</SUP>_ or -S(=O)<SUB>n1</SUB>,-NR<SUP>5</SUP> -(CH<SUB>2</SUB>)<SUB>n3</SUB>-; R<SUP>3</SUP> represents an optionally substituted 5-or 6-membered monocyclic heterocycle containing at least one heteroatom selected from 0, S or N, or a 9-or 10-membered bicyclic heterocycle containing at least one heteroatom selected from 0, S or N; R<SUP>4</SUP> represents hydrogen; halo; hydroxy; optionally substituted C<SUB>1-4</SUB>alkyl; optionally substituted C<SUB>2-4</SUB>alkenyl or C<SUB>2-4</SUB>alkynyl; polyhaloC<SUB>1-3</SUB>alkyl; optionally substituted C<SUB>1-4</SUB>alkyloxy; polyhaloC<SUB>1-3</SUB>alkyloxy; C<SUB>1-4</SUB>alkylthio; polyhaloC<SUB>1-3</SUB>alkylthio; C<SUB>1-4</SUB>alkyloxycarbonyl; C<SUB>1-4</SUB>alkylcarbonyloxy; C<SUB>1-4</SUB>alkylcarbonyl; polyhaloC<SUB>1-4</SUB>alkylcarbonyl; nitro; cyano; carboxyl; NR<SUP>9</SUP>R<SUP>10</SUP>; C(=O)NR<SUP>9</SUP>R<SUP>10</SUP>;-NR<SUP>5_</SUP>C(=O)-NR<SUP>9</SUP>R<SUP>10</SUP>; -NR<SUP>5</SUP>-C(=O)-R<SUP>5</SUP>; -S(=O) <SUB>n1</SUB>,-R<SUP>11</SUP> -NR<SUP>5</SUP>-S(=O)<SUB>n1</SUB>,-R<SUP>11</SUP> -S-CN; -NR<SUP>5</SUP> -CN; their use, pharmaceutical compositions comprising them and processes for their preparation.
申请公布号 WO2005012304(A3) 申请公布日期 2007.04.26
申请号 WO2004EP51457 申请日期 2004.07.12
申请人 JANSSEN PHARMACEUTICA N.V.;FREYNE, EDDY, JEAN, EDGARD;LOVE, CHRISTOPHER, JOHN;COOYMANS, LUDWIG, PAUL;VANDERMAESEN, NELE;BUIJNSTERS, PETER, JACOBUS, JOHANNES, ANTONIUS;WILLEMS, MARC;EMBRECHTS, WERNER, CONSTANT, JOHAN 发明人 FREYNE, EDDY, JEAN, EDGARD;LOVE, CHRISTOPHER, JOHN;COOYMANS, LUDWIG, PAUL;VANDERMAESEN, NELE;BUIJNSTERS, PETER, JACOBUS, JOHANNES, ANTONIUS;WILLEMS, MARC;EMBRECHTS, WERNER, CONSTANT, JOHAN
分类号 C07D487/04;A61K31/519;A61P3/10;A61P25/24;C07D235/00;C07D249/00 主分类号 C07D487/04
代理机构 代理人
主权项
地址